(Q53176650)

English

Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.

scientific article published in December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17852440

Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study. (English)

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17852440

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

Nabil Abdelrazik

1

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17852440

Manal Fouda

2

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17852440

publication date

1 December 2007

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17852440

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17852440

12

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17852440

6

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17852440

533-541

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17852440

Anaemia in cancer: pathophysiology and treatment.

1 reference

https://api.crossref.org/works/10.1080%2F10245330701521572

21 January 2018

Treatment with recombinant human erythropoietin in children with malignancies.

1 reference

https://api.crossref.org/works/10.1080%2F10245330701521572

21 January 2018

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.

1 reference

https://api.crossref.org/works/10.1080%2F10245330701521572

21 January 2018

Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin.

1 reference

https://api.crossref.org/works/10.1080%2F10245330701521572

21 January 2018

Recombinant erythropoietin in acute chemotherapy-induced anemia of children with cancer.

1 reference

https://api.crossref.org/works/10.1080%2F10245330701521572

21 January 2018

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.

1 reference

https://api.crossref.org/works/10.1080%2F10245330701521572

21 January 2018

Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial

1 reference

https://api.crossref.org/works/10.1080%2F10245330701521572

21 January 2018

Pure red-cell aplasia and epoetin therapy.

1 reference

https://api.crossref.org/works/10.1080%2F10245330701521572

21 January 2018

Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study

1 reference

https://api.crossref.org/works/10.1080%2F10245330701521572

21 January 2018

Identifiers

10.1080/10245330701521572

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17852440

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/17852440

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53176650&oldid=1586488306"